• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂和顺-[PtI(NH)]与相关蛋白侧链分子模型的反应:比较分析。

Reactions of cisplatin and cis-[PtI(NH)] with molecular models of relevant protein sidechains: A comparative analysis.

机构信息

Dipartimento di Farmacia, Università degli Studi "G. D'Annunzio" Chieti-Pescara, Via dei Vestini, I-66100 Chieti, Italy.

Department of Pharmacy, University of Pisa, via Bonanno Pisano 6, 56126 Pisa, Italy.

出版信息

J Inorg Biochem. 2020 Aug;209:111096. doi: 10.1016/j.jinorgbio.2020.111096. Epub 2020 May 16.

DOI:10.1016/j.jinorgbio.2020.111096
PMID:32485478
Abstract

Quite surprisingly, cisplatin and cis-[PtI(NH)] were found to manifest significant differences in their reactions with the model protein lysozyme. We decided to explore whether these differences recur when reacting these two Pt compounds with other proteins. Notably, ESI-MS measurements carried out on cytochrome c nicely confirmed the reaction pattern observed for lysozyme. This prompted us to exploit a computational DFT approach to disclose the molecular basis of such behavior. We analyzed comparatively the reactions of cis-[PtCl(NH)] and cis-[PtI(NH)] with appropriate molecular models (Ls) of the sidechains of relevant aminoacids. We found that when Pt(II) complexes are reacted with sulfur ligands both quickly lose their halide ligands and then the resulting cis-[Pt(L)(NH)] species loses ammonia upon reaction with a ligand excess. In the case of imidazole, again cis-[PtCl(NH)] and cis-[PtI(NH)] quickly lose their halide ligands but the resulting cis-[Pt(L)(NH)] species does not lose ammonia by reaction with excess imidazole. These results imply that the two platinum complexes manifest a significantly different behavior in their reaction with representative small molecules in agreement with what observed in the case of model proteins. It follows that the protein itself must play a crucial role in triggering the peculiar reactivity of cis-[PtI(NH)] and in governing the nature of the formed protein adducts. The probable reasons for the observed behavior are critically commented and discussed.

摘要

令人惊讶的是,顺铂和顺-[PtI(NH)]在与模型蛋白溶菌酶的反应中表现出显著的差异。我们决定探索当这两种 Pt 化合物与其他蛋白质反应时,这些差异是否会重现。值得注意的是,ESI-MS 测量对细胞色素 c 的测量很好地证实了溶菌酶观察到的反应模式。这促使我们利用计算 DFT 方法揭示这种行为的分子基础。我们比较分析了顺-[PtCl(NH)]和顺-[PtI(NH)]与相关氨基酸侧链适当分子模型(Ls)的反应。我们发现,当 Pt(II) 配合物与硫配体反应时,它们会迅速失去卤化物配体,然后所得的 cis-[Pt(L)(NH)]物种在与配体过量反应时失去氨。对于咪唑,顺-[PtCl(NH)]和顺-[PtI(NH)]再次迅速失去卤化物配体,但所得的 cis-[Pt(L)(NH)]物种不会与过量咪唑反应而失去氨。这些结果表明,两种铂配合物在与代表性小分子的反应中表现出明显不同的行为,与在模型蛋白中的观察结果一致。因此,蛋白质本身必须在引发顺-[PtI(NH)]的特殊反应性和控制形成的蛋白质加合物的性质方面发挥关键作用。对观察到的行为的可能原因进行了批判性评论和讨论。

相似文献

1
Reactions of cisplatin and cis-[PtI(NH)] with molecular models of relevant protein sidechains: A comparative analysis.顺铂和顺-[PtI(NH)]与相关蛋白侧链分子模型的反应:比较分析。
J Inorg Biochem. 2020 Aug;209:111096. doi: 10.1016/j.jinorgbio.2020.111096. Epub 2020 May 16.
2
Peculiar features in the crystal structure of the adduct formed between cis-PtI2(NH3)2 and hen egg white lysozyme.顺铂二氨络合物与鸡卵清白蛋白溶菌酶加合物晶体结构的独特特征。
Inorg Chem. 2013 Dec 16;52(24):13827-9. doi: 10.1021/ic402611m. Epub 2013 Nov 20.
3
A first-in-class and a fished out anticancer platinum compound: cis-[PtCl2(NH3)2] and cis-[PtI2(NH3)2] compared for their reactivity towards DNA model systems.一种首创的和一种已开发殆尽的抗癌铂化合物:顺式-[PtCl₂(NH₃)₂] 和顺式-[PtI₂(NH₃)₂] 对DNA模型系统的反应活性比较
Dalton Trans. 2016 May 28;45(20):8587-600. doi: 10.1039/c6dt00294c. Epub 2016 Apr 29.
4
The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).新型抗肿瘤化合物顺式-[Pt(NH₃)₂(4-甲基吡啶)Cl]Cl不会与DNA形成N7,N7-d(GpG)螯合物。在d(GpG)中,铂对5'G具有意想不到的结合偏好。
J Inorg Biochem. 1990 Sep;40(1):23-35. doi: 10.1016/0162-0134(90)80037-x.
5
Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.在含有双齿氮、氧供体吡啶-2-基乙酸酯的结构新颖的铂(II)配合物中,细胞毒性的顺式几何要求发生了反转。
Inorg Chem. 2000 May 1;39(9):1882-90. doi: 10.1021/ic991259p.
6
Elusive intermediates in cisplatin reaction with target amino acids: Platinum(II)-cysteine complexes assayed by IR ion spectroscopy and DFT calculations.顺铂与靶氨基酸反应中的中间产物难以捉摸:通过红外离子光谱和密度泛函理论计算测定铂(II)-半胱氨酸配合物。
J Inorg Biochem. 2022 Dec;237:112017. doi: 10.1016/j.jinorgbio.2022.112017. Epub 2022 Oct 1.
7
Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c.基于一个案例研究对蛋白质铂化分子机制的见解:抗癌铂(II)亚氨基醚与马心细胞色素c的反应
Biochemistry. 2007 Oct 30;46(43):12220-30. doi: 10.1021/bi701516q. Epub 2007 Oct 9.
8
Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2].胺非离去基团对顺式-[Pt(R-NH₂)₂(NO₃)₂]与DNA复合物的结构和稳定性的影响。
Eur J Biochem. 1991 Dec 18;202(3):975-80. doi: 10.1111/j.1432-1033.1991.tb16458.x.
9
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme.抗癌铂类药物与鸡蛋清溶菌酶加合物的电喷雾电离质谱及X射线衍射研究
Chem Commun (Camb). 2007 Jan 14(2):156-8. doi: 10.1039/b611122j. Epub 2006 Oct 26.
10
Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.奥沙利铂与大黄酸和阿魏酸的配合物作为具有高抗肿瘤活性的铂(IV)前药。
Dalton Trans. 2020 Feb 7;49(5):1613-1619. doi: 10.1039/c9dt04594e. Epub 2020 Jan 16.

引用本文的文献

1
Identification of Platinum(II) Sulfide Complexes Suitable as Intramuscular Cyanide Countermeasures.鉴定适合作为肌肉内氰化物解毒剂的二价铂硫化物配合物。
Chem Res Toxicol. 2022 Nov 21;35(11):1983-1996. doi: 10.1021/acs.chemrestox.2c00157. Epub 2022 Oct 6.
2
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues.含不同配体的药用高铼前药:AS101 及其卤化物取代类似物的化学特征比较研究。
Int J Mol Sci. 2022 Jul 6;23(14):7505. doi: 10.3390/ijms23147505.
3
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study.
砷铂-1 与蛋白质靶标的反应:实验与理论的综合研究。
Inorg Chem. 2022 Feb 21;61(7):3240-3248. doi: 10.1021/acs.inorgchem.1c03732. Epub 2022 Feb 9.
4
Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action.顺铂与寡核苷酸-肽混合物的同时质谱分析:对作用机制的启示。
J Biol Inorg Chem. 2022 Mar;27(2):239-248. doi: 10.1007/s00775-022-01924-9. Epub 2022 Jan 22.
5
Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey.基于计算化学的金(I)和金(III)抗癌配合物的研究综述
Molecules. 2021 Dec 15;26(24):7600. doi: 10.3390/molecules26247600.
6
In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study.基于计算研究的选定金属化合物的体外抗 SARS-CoV-2 活性及其作用的潜在分子基础。
Biomolecules. 2021 Dec 10;11(12):1858. doi: 10.3390/biom11121858.
7
Strategies for the Improvement of Metal-Based Chemotherapeutic Treatments.改善金属基化疗治疗的策略。
Biomedicines. 2021 May 4;9(5):504. doi: 10.3390/biomedicines9050504.
8
New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells.新型铂(II)配合物对耐药卵巢癌细胞中不同生物分子靶标的影响。
ChemMedChem. 2021 Jun 17;16(12):1956-1966. doi: 10.1002/cmdc.202100075. Epub 2021 Apr 6.
9
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt)I: A Theoretical and Experimental Study.金诺芬类似物Au(PEt)I抗癌特性的作用机制洞察:一项理论与实验研究
Front Chem. 2020 Sep 18;8:812. doi: 10.3389/fchem.2020.00812. eCollection 2020.
10
An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the Pt Linker Lx for Improved Manufacturability of Antibody-Drug Conjugates.一种通过 Pt 连接子 Lx 将药物偶联到天然抗体上的高效偶联方法,可提高抗体药物偶联物的制造可行性。
Angew Chem Int Ed Engl. 2021 Feb 8;60(6):3008-3015. doi: 10.1002/anie.202011593. Epub 2021 Jan 15.